DeutschNewstral
Article
metro.us on 2017-08-14 03:36
China's Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor
Related news
- SBid for KKR-backed Indian drugmaker Gland ‘non-binding’, says China’s Fosun Pharmascmp.com
- China's Fosun says online rumors about chairman false after shares fallmetro.us
China's Fosun to Invest More Overseaswsj.com- China's Xi says Shanghai should lead in reform, innovation: Xinhuametro.us
Rare public protest in China's Shanghai over property rule changeSydney Morning Herald- Mayor of China's Shanghai steps down in reshuffle: city governmentmetro.us
- PFive dead in building collapse in China's Shanghaipresstv.com
- FFosun revises its offer for India’s Gland Pharmaft.com
Shanghai Tower: China's Tallest BuildingForbes- China's Fosun To Set Up Online Small Loan ProviderForbes
- China's Fosun To Build Condo Tower In New YorkForbes
Cirque du Soleil sells stakes to TPG, China's FosunLA Times- China's Fosun to Pull Back on Foreign Buying Spreewsj.com
China's Shanghai lockdown tests ‘zero-COVID’ strategyFox News- SFosun Pharma to spin-off and list Sisram Medical in Hong Kongscmp.com
- Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine BiotechForbes
'Didn't dare believe it': Frustrated Shanghai residents question China's 'cruel' Covid policiesThe Times of India- TTransport locked down in China's Shanghai as asymptomatic COVID cases surgetorontosun.com
Angry Shanghai videos test China's 'Great Firewall'BBC
Shanghai lockdown tests China's 'zero-COVID' limitsCBC